MUC1 and breast carcinoma: We thus hypothesize that breast cancer cells displaying mem-PankoMab-GEXTM positivity are predisposed to be recognized by endogenous or newly induced anti-MUC1 auto-antibodies potentially acting via ADCC mechanisms, as demonstrated for PankoMab-GEXTM [6].